Florent Leturcq

Florent Leturcq

Auto-generated profile, based on publicly available information

Florent Leturcq

INSERM UMR 1163, Laboratory of Genetic Skin Diseases, Imagine Institute and University of Paris, Paris, France

Research Focus & Metrics

Academic Career Length

7Years (2020-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 June 2020 in Journal of Investigative Dermatology
Verified
Journal Article
Closed access
OGOlivier Gouin
Olivier Gouin
CBClaire Barbieux
Claire Barbieux
FLFlorent Leturcq
Florent Leturcq
MCMathilde Bonnet Des Claustres
Mathilde Bonnet Des Claustres
EPEvgeniya Petrova
Evgeniya Petrova
AHAlain HOVNANIAN
Alain HOVNANIAN

5 February 2024 in Communications Biology
Verified
Journal Article
Open access
PDF file
EPEvgeniya Petrova
Evgeniya Petrova
JLJesús María López-Gay
Jesús María López-Gay
MFMatthias Fahrner
Matthias Fahrner
FLFlorent Leturcq
Florent Leturcq
JVJean-Pierre de Villartay
Jean-Pierre de Villartay
AHAlain HOVNANIAN
Alain HOVNANIAN
Netherton syndrome (NS) is a rare skin disease caused by loss-of-function mutations in the serine peptidase inhibitor Kazal type 5 (SPINK5) gene. Disease severity and the lack of efficacious treatments call for a better understanding of NS mechanisms. Here we describe a novel and viable, Spink5 conditional knock-out (cKO) mouse model, allowing to study NS progression. By combining transcriptomics and proteomics, we determine a disease molecular profile common to mouse models and NS patients. Spink5 cKO mice and NS patients share skin barrier and inflammation signatures defined by up-regulation and increased activity of proteases, IL-17, IL-36, and IL-20 family cytokine signaling. Systemic inflammation in Spink5 cKO mice correlates with disease severity and is associated with thymic atrophy and enlargement of lymph nodes and spleen. This systemic inflammation phenotype is marked by neutrophils and IL-17/IL-22 signaling, does not involve primary T cell immunodeficiency and is independent of bacterial infection. By comparing skin transcriptomes and proteomes, we uncover several putative substrates of tissue kallikrein-related proteases (KLKs), demonstrating that KLKs can proteolytically regulate IL-36 pro-inflammatory cytokines. Our study thus provides a conserved molecular framework for NS and reveals a KLK/IL-36 signaling axis, adding new insights into the disease mechanisms and therapeutic targets.